HomeBiosciences

Biosciences

Industry Catalyst BioscienceLA Relaunches

Howard Fine - October 28, 2024

Biosciences

Atara Shareholders Approve Reverse Stock Split

Mark R. Madler - June 24, 2024

Biosciences

Fulgent Announces Second Drug in Development and New Prenatal Genetic Test

Howard Fine - May 20, 2024

Biosciences

Canine Vaccine: Anivive Seeks Fungal History

Zane Hill - May 29, 2023

Biosciences

L.A. is Key Center for Cancer Immunotherapy R&D

HOWARD FINE - March 13, 2023

Biosciences

Bioscience Special Report – Cancer Fighters

HOWARD FINE - March 13, 2023

Biosciences

Local Companies and Research Institutes at Forefront of Cancer Immunotherapy Development

HOWARD FINE - March 13, 2023

Biosciences

24 Hour Home Care Expands into New Mexico

HOWARD FINE - January 2, 2023

Biosciences

Kite Acquires 50% Stake in Cancer Drug Developed by Bay Area Pharma Co Arcellx

Howard Fine - January 2, 2023

Biosciences

Soon-Shiong Pumps Another $107 Million into ImmunityBio

HOWARD FINE - January 2, 2023

Biosciences

Time BioVentures Launches $100M Fund

MARK R. MADLER - October 31, 2022

Biosciences

Industry Catalyst BioscienceLA Relaunches

Atara Shareholders Approve Reverse Stock Split

Fulgent Announces Second Drug in Development and New Prenatal Genetic Test

Canine Vaccine: Anivive Seeks Fungal History

L.A. is Key Center for Cancer Immunotherapy R&D

Bioscience Special Report – Cancer Fighters

Local Companies and Research Institutes at Forefront of Cancer Immunotherapy Development

24 Hour Home Care Expands into New Mexico

Kite Acquires 50% Stake in Cancer Drug Developed by Bay Area Pharma Co Arcellx

Soon-Shiong Pumps Another $107 Million into ImmunityBio

Time BioVentures Launches $100M Fund

Advertise with Us

About Us

Membership Center

Other Journals